Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.
about
ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association.Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.Cardiovascular comorbidity in rheumatic diseases.Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
P2860
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@ast
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@en
type
label
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@ast
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@en
prefLabel
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@ast
Asymmetric dimethylarginine as ...... h systemic rheumatic diseases.
@en
P2860
P356
P1476
Asymmetric dimethylarginine as ...... th systemic rheumatic diseases
@en
P2093
Aamer Sandoo
P2860
P304
12315-12335
P356
10.3390/IJMS131012315
P407
P5008
P577
2012-09-26T00:00:00Z